LOT Nasdaq Motor Vehicles & Passenger Car Bodies Financials FY2021βFY2025
Lotus Technology Inc. had $519M of revenue in fiscal 2025, down 43.8% on the year before.
Hi! I read Lotus Technology Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β43.8%
No. Sales fell 43.8% last year.
Does it make a profit?
β89.4%
No. It lost money last year.
Does profit turn into cash?
β79.6%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 9
Weak. It passes 3 of 9 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· Lotus Technology Inc. had $519M of revenue in fiscal 2025, down 43.8% on the year before. Its operating margin was β81.5%, up 3.5Β pts: of every 100 in sales, about β82 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Margins, % of revenue
KIRA Β· Lotus Technology Inc. lost $464M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$413M in fiscal 2025, β79.6% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Lotus Technology Inc. owes $1.3B more than it holds in cash.
Cash, debt and the ratios that show how comfortably Lotus Technology Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $531M | $737M | $419M | $103M | $73.4M |
| Debt incl. finance leases | $126M | $456M | $681M | $906M | $1.4B |
| Debt / equity | 0.6x | β | β | β | β |
| Interest coverage | β31.2x | β80.5x | β72.2x | β13.5x | β6.7x |
| Current ratio | β | 0.9x | 0.5x | 0.4x | 0.4x |
| Quick ratio | β | 0.9x | 0.4x | 0.3x | 0.3x |
| Total assets | β | $1.4B | $1.6B | $2.3B | $2.0B |
| Total liabilities | β | $1.5B | $2.4B | $3.1B | $3.3B |
| Shareholders' equity | $195M | β$452M | β$1.2B | β$853M | β$1.3B |
| Net debt (β = net cash) | β$405M | β$281M | $262M | $802M | $1.3B |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Lotus Technology Inc. passes 3 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 4 / 9 | 2 / 9 | 3 / 9 |
| Accruals ratio | β | β27.2% | β24.0% | β13.2% | β6.1% |
| Altman Z'' | β | β6.23 | β10.53 | β10.53 | β12.15 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.7M | $9.6M | $679M | $924M | $519M |
| Gross profit | $0.6M | $2.3M | $102M | $29.6M | $45.2M |
| Research and development | $511M | $446M | $369M | $275M | $171M |
| Operating income | β$113M | β$687M | β$736M | β$786M | β$423M |
| Interest expense | $3.6M | $8.5M | $10.2M | $58.2M | $63.3M |
| Pretax income | β$109M | β$724M | β$749M | β$1.1B | β$450M |
| Income tax | $1.9M | $0.3M | $1.1M | $2.0M | $15.9M |
| Net income | β$111M | β$724M | β$742M | β$1.1B | β$464M |
| Net income to common | β$111M | β$725M | β$757M | β$1.1B | β$464M |
| Diluted EPS | β$0.33 | β$1.52 | β$1.60 | β$1.72 | β$0.72 |
| Diluted shares | 0.33B | 0.48B | 0.47B | 0.65B | 0.65B |
| Cash flow | |||||
| Cash from operations | β$127M | β$351M | β$387M | β$849M | β$334M |
| Capital expenditure | $34.6M | $133M | $214M | $57.3M | $79.4M |
| Free cash flow | β$161M | β$485M | β$601M | β$906M | β$413M |
| Depreciation and amortization | $2.1M | $12.8M | $55.0M | $76.5M | $54.7M |
| Stock-based compensation | β | $10.6M | $0.0M | $31.9M | $2.3M |
| Dividends paid | $1.9M | β | β | β | β |
| Dividends and buybacks | $1.9M | β | β | β | β |
| Balance sheet | |||||
| Cash and short-term investments | $531M | $737M | $419M | $103M | $73.4M |
| Total debt | $126M | $456M | $681M | $906M | $1.4B |
| Current assets | β | $823M | $884M | $1.0B | $911M |
| Current liabilities | β | $933M | $1.8B | $2.5B | $2.4B |
| Inventory | β | $22.7M | $265M | $189M | $121M |
| Property and equipment, net | β | $253M | $355M | $316M | $227M |
| Intangible assets | β | $116M | $116M | $117M | $116M |
| Total assets | β | $1.4B | $1.6B | $2.3B | $2.0B |
| Total liabilities | β | $1.5B | $2.4B | $3.1B | $3.3B |
| Shareholders' equity | $195M | β$452M | β$1.2B | β$853M | β$1.3B |
| Margins | |||||
| Gross margin | 15.1% | 24.1% | 15.0% | 3.2% | 8.7% |
| Operating margin | β3,063.2% | β7,192.8% | β108.4% | β85.1% | β81.5% |
| EBITDA margin | β3,007.5% | β7,058.9% | β100.3% | β76.8% | β71.0% |
| Net margin | β2,997.9% | β7,574.8% | β109.3% | β119.5% | β89.4% |
| FCF margin | β4,369.3% | β5,072.3% | β88.5% | β98.0% | β79.6% |
| Returns | |||||
| Return on capital employed | β | β156.6% | 426.4% | 432.7% | 95.0% |
| Return on equity | β56.6% | β | β | β | β |
| Return on assets | β | β52.8% | β50.2% | β57.1% | β21.9% |
| Return on tangible equity | β56.6% | β | β | β | β |
| Growth | |||||
| Revenue growth | β | 159.2% | 7,004.8% | 36.1% | β43.8% |
| Share count change | β | 42.4% | β0.2% | 35.9% | 0.5% |
| Financial health | |||||
| Debt / equity | 0.6x | β | β | β | β |
| Interest coverage | β31.2x | β80.5x | β72.2x | β13.5x | β6.7x |
| Current ratio | β | 0.9x | 0.5x | 0.4x | 0.4x |
| Quick ratio | β | 0.9x | 0.4x | 0.3x | 0.3x |
| Capital allocation | |||||
| Capex / revenue | 938.2% | 1,395.3% | 31.5% | 6.2% | 15.3% |
| Stock comp / revenue | β | 111.2% | 0.0% | 3.5% | 0.4% |
| Quality scores | |||||
| Piotroski F-score | β | β | 4.0 | 2.0 | 3.0 |
| Altman Z'' | β | β6.2 | β10.5 | β10.5 | β12.1 |
| Accruals ratio | β | β27.2% | β24.0% | β13.2% | β6.1% |
Source: SEC EDGAR XBRL filings (CIK 0001962746). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
